The honey and wellness foods maker posted a sharp divergence between its top and bottom lines, with a major inventory release boosting margins.
Apis India's Q1 FY27 saw profit rise 34% year-on-year to ₹3.39 crore, even as revenue fell 24% to ₹65.96 crore. The gain was driven by lower material costs and a significant one-off inventory adjustment.
For Apis India, a leading name in branded honey and wellness foods, the June quarter presented a puzzle. Sales fell sharply, yet profits rose. The answer lies in a strategic inventory drawdown and cost management that temporarily insulated the bottom line from a broader consumer slowdown.
Revenue for Q1 FY27 was ₹65.96 crore, down 24.1% from a year ago and 32.6% from the previous quarter. Profit, however, climbed 34% year-on-year to ₹3.39 crore, though it fell 67% sequentially. The net profit margin expanded by 220 basis points to 5.1%.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 (Jun 2026) | PreviousQ4 FY26 (Mar 2026) |
|---|---|---|
| Revenue (₹ Cr) | 65.96 | 97.89 |
| Profit (₹ Cr) | 3.39 | 10.35 |
| Net Profit Margin (%) | 5.1 | 10.6 |
The profit growth was operational, not from other income. According to a report by ScanX, the cost of materials consumed fell 23.6%, closely tracking the revenue decline. More crucially, a positive inventory adjustment of ₹10.04 crore against expenses, compared to a negative adjustment a year ago, provided a major boost. This release of previously stocked goods, combined with lower other expenses, more than offset higher employee and finance costs.
The revenue drop reflects a tough environment for FMCG companies. Data from NIQ cited by Moneycontrol shows the Indian FMCG market saw volumes decline 2% in the April-June quarter, with rural markets particularly weak. For a company like Apis, which competes with giants like Dabur and Patanjali, this translated into lower offtake. The quarter's performance was also likely affected by a delayed results announcement, as noted by Multibagg.ai, due to an extended auditor review.
Management's focus appears to be on expansion and efficiency for the long term. The company is setting up an in-house jam manufacturing facility in Roorkee, supported by a government subsidy, as reported by UNI. Analysis from Sector Alpha shows the company spent ₹11 crore on capital expenditure in FY26, funded from cash, not new debt. This points to a strategy of backward integration and capacity building, even as near-term sales face headwinds.
Live Chart
· APIS
(BSE)
ISIN: INE070K01014
Key Points
This quarter highlights Apis India's ability to manage costs under pressure, but the sustainability of profit growth is in question. The inventory release that flattered margins is a one-time benefit that cannot be repeated. The core challenge remains reviving sales volume in a sluggish consumer market, especially in rural areas. The company's investments in new product categories like masala dates and in-house manufacturing are bets on future growth. Their success, and a recovery in broader consumer sentiment, will determine if Apis can return to a path of consistent top-line expansion alongside healthy profitability.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.